Though the putative antitumor potential of statins is already studied and might be attributed to their direct effect ontumor cells, downregulating PD-L1 [45] and suppressing tumor escape by inhibiting PD-L1 trafficking [10], statins’ effect on anti-PD-1-related CVAEs is not yet investigated. This evidence concerns the gene PDCD1 and neoplasm.